Yasuhi Ichiro, Myoga Mai, Suga Sachie, Sugimi So, Umezaki Yasushi, Fukuda Masashi, Yamashita Hiroshi, Kusuda Nobuko
Department of Obstetrics & Gynecology, Nagasaki Medical Center, Omura, Nagasaki, Japan.
Department of Obstetrics & Gynecology, School of Medicine, University of Occupational and Environmental Health, Fukuoka, Japan.
J Obstet Gynaecol Res. 2017 Mar;43(3):486-491. doi: 10.1111/jog.13242. Epub 2016 Dec 27.
In spite of the recommendation for rescue antenatal corticosteroids (ACS), the optimal time interval between primary and rescue courses has not been clearly demonstrated. The aim of this study was to determine the effects of the interval between a single ACS course and delivery on the incidence of respiratory distress syndrome (RDS).
In this retrospective study, we included singleton pregnant women who received a single course of ACS and delivered beyond 48 h after ACS administration between 24 and 33 weeks' gestation. The risk of RDS was compared between patients who delivered within seven days (Group I), 7-14 days (Group II) and beyond 14 days (Group III) after ACS administration.
We included 83, 14 and 20 patients in Groups I, II and III, respectively. After adjusting for confounders, the ACS delivery interval was significantly associated with RDS in Group II (adjusted odds ratio 12.8, 95% confidence interval 1.31-164.7) and Group III (adjusted odds ratio 64.0, 95% confidence interval 1.32-5808.6).
A longer ACS delivery interval is associated with a higher risk of RDS. Thus, the use of a rescue course could be expected to reduce the incidence of RDS in patients beyond seven days after ACS administration who remain at risk for preterm delivery within seven days, especially in cases of placenta previa and/or women bearing a male fetus.
尽管推荐使用挽救性产前糖皮质激素(ACS),但初次用药与挽救性用药疗程之间的最佳时间间隔尚未明确。本研究的目的是确定单次ACS疗程与分娩之间的时间间隔对呼吸窘迫综合征(RDS)发生率的影响。
在这项回顾性研究中,我们纳入了在妊娠24至33周期间接受单次ACS疗程且在ACS给药后48小时以上分娩的单胎孕妇。比较了在ACS给药后7天内(I组)、7 - 14天(II组)和14天以上(III组)分娩的患者发生RDS的风险。
I组、II组和III组分别纳入了83例、14例和20例患者。在对混杂因素进行调整后,ACS给药至分娩的时间间隔在II组(调整后的优势比为12.8,95%置信区间为1.31 - 164.7)和III组(调整后的优势比为64.0,95%置信区间为1.32 - 5808.6)中与RDS显著相关。
ACS给药至分娩的时间间隔越长,发生RDS的风险越高。因此,对于在ACS给药后7天以上且在接下来7天内仍有早产风险的患者,尤其是前置胎盘和/或怀有男性胎儿的女性,使用挽救性疗程有望降低RDS的发生率。